Enterprise 2.0: Research challenges and opportunities

© Springer International Publishing Switzerland 2015. Blending Web 2.0 technologies with enterprise information systems is setting up the stage for a new generation of information systems that will help enterprises open up new communication channels with their stakeholders. Contrary to traditional enterprises with top-down command flow and bottom-up feedback flow, the same flows in Enterprise 2.0 cross all levels and in all directions bringing people together in the development of creative and innovative ideas. The power of Web 2.0 technologies stems from their ability to capture real-world phenomena such as collaboration, competition, and partnership that can be converted into useful and structured information sources from which enterprises can draw information about markets’ trends, consumers’ habits, suppliers’ strategies, etc. This paper discusses the research efforts that our international research group has put into the topic of Enterprise 2.0 (aka Social Enterprise). In particular, our research group advocates that existing practices for managing enterprise information systems need to be re-visited in a way that permits to capture social relations that arise inside and outside the enterprise, to establish guidelines and techniques to assist IT practitioners integrate social relations into their design, development, and maintenance efforts of these information systems, and last but not least to identify and tackle challenges that prevent capturing social relations

Design, synthesis and antiparasitic evaluation of click phospholipids

A library of seventeen novel ether phospholipid analogues, containing 5-membered heterocyclic rings (1,2,3-triazolyl, isoxazolyl, 1,3,4-oxadiazolyl and 1,2,4-oxadiazolyl) in the lipid portion were designed and synthesized aiming to identify optimised miltefosine analogues. The compounds were evaluated for their in vitro antiparasitic activity against Leishmania infantum and Leishmania donovani intracellular amastigotes, against Trypanosoma brucei brucei and against different developmental stages of Trypanosoma cruzi. The nature of the substituents of the heterocyclic ring (tail) and the oligomethylene spacer between the head group and the heterocyclic ring was found to affect the activity and toxicity of these compounds leading to a significantly improved understanding of their structure\u2013activity relationships. The early ADMET profile of the new derivatives did not reveal major liabilities for the potent compounds. The 1,2,3-triazole derivative 27 substituted by a decyl tail, an undecyl spacer and a choline head group exhibited broad spectrum antiparasitic activity. It possessed low micromolar activity against the intracellular amastigotes of two L. infantum strains and T. cruzi Y strain epimastigotes, intracellular amastigotes and trypomastigotes, while its cytotoxicity concentration (CC50) against THP-1 macrophages ranged between 50 and 100 \ub5M. Altogether, our work paves the way for the development of improved ether phospholipid derivatives to control neglected tropical diseases

3-Phenylcoumarins as Inhibitors of HIV-1 Replication

We have synthesized fourteen 3-phenylcoumarin derivatives and evaluated their anti-HIV activity. Antiviral activity was assessed on MT-2 cells infected with viral clones carrying the luciferase gene as reporter. Inhibition of HIV transcription and Tat function were tested on cells stably transfected with the HIV-LTR and Tat protein. Six compounds displayed NF-κB inhibition, four resulted Tat antagonists and three of them showed both activities. Three compounds inhibited HIV replication with IC50 values < 25 μM. The antiviral effect of the 4-hydroxycoumarin derivative 19 correlates with its specific inhibition of Tat functions, while compound 8, 3-(2-chlorophenyl)coumarin, seems to act through a mechanism unrelated to the molecular targets considered in this research